Consolidated Statement of Changes in Shareholders' Equity / (Deficiency) (Unaudited) - 9 months ended Sep. 30, 2016 - USD ($)		Total	Common Stock		Additional Paid-In Capital	[1]	Accumulated Deficit
Balance at Dec. 31, 2015		$ (18,309)	$ 3,127	[1]	$ 146,856,143		$ (146,877,579)
Balance, Shares at Dec. 31, 2015	[1]		3,126,952
Issuance of common stock pursuant to Lincoln Park Equity Line		1,639,110	$ 267	[1]	1,638,843
Issuance of common stock pursuant to Lincoln Park Equity Line, Shares	[1]		266,830
Costs associated with Lincoln Park Equity Line		(41,381)		[1]	(41,381)
Issuance of common stock to SciClone		3,000,000	$ 353	[1]	2,999,647
Issuance of common stock to SciClone, Shares	[1]		352,942
Issuance of common stock to vendors		52,500	$ 8	[1]	52,492
Issuance of common stock to vendors, Shares	[1]		7,500
Share-based compensation expense		453,935		[1]	453,935
Net loss		(2,915,424)		[1]			(2,915,424)
Balance at Sep. 30, 2016		$ 2,170,431	$ 3,755	[1]	$ 151,959,679		$ (149,793,003)
Balance, Shares at Sep. 30, 2016	[1]		3,754,224

[1] Adjusted to reflect the reverse stock split of one-for-ten effective October 7, 2016.